Rockwell Medical, Inc. (RMTI) vs Talphera, Inc. (TLPH)

Rockwell Medical, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $52.4M against $30.6M — 1.7× the size. Rockwell Medical, Inc. grew revenue faster over the last twelve months: −21.1% against −73.1%. Talphera, Inc. has the higher net margin (0.00% vs −7.33%) and the higher return on invested capital (0.00% vs −14.6%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 10 and Talphera, Inc. on 8.

Valuation

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.44 180.84 2.08
P/B 0.87 5.35 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.21 155.68 2.87
Earnings yield (17.40%) (26.47%) (15.94%)
Free cash flow yield (3.22%) (12.52%) 0.00%

Profitability

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Gross margin 17.71% 100.00% 53.51%
Operating margin (6.52%) 0.00% 0.00%
Net margin (7.33%) 0.00% (2.45%)
Free cash flow margin 2.47% 0.00% 0.00%
Return on equity (15.53%) (143.36%) (0.80%)
Return on assets (9.32%) (69.60%) (1.67%)
Return on invested capital (14.58%) 0.00% 0.00%

Growth

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (21.12%) (73.07%) 5.22%
EPS growth (last fiscal year) (870.87%) 32.00% 42.91%
Revenue growth, 5-year CAGR 2.17% (58.55%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.26 0.00 0.04
Current ratio 3.25 4.29 2.41
Net debt to EBITDA 7.40 1.50 1.01

Dividend

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric RMTI TLPH Drug Manufacturers Specialty & Generic median
Market cap 30.64m 52.42m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack